Acromegaly Market Poised for Significant Expansion During the Forecast Period (2026-2036) as New Treatment Options Emerge | DelveInsight
Acromegaly Market Poised for Significant Expansion During the Forecast Period (2026-2036) as New Treatment Options Emerge | DelveInsight
Ascendis Pharma (ASND) Revenue Nearly Doubles to €720M in 2025 Fueled by Core Product Growth [Yahoo! Finance]
The Boston Globe to Host Rare Disease Summit
Ascendis Pharma A/S (NASDAQ:ASND) was given a new $325.00 price target on by analysts at Stifel Nicolaus.